Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

$11.22 -0.22 (-1.92%)

High $11.49	Low $11.20	Trades 4,718	Turnover $7,499,551	Volume 664,557
30 June 2023 at 4:12pm

Market Cap (26-Oct) $4,481,754,624 (204th)	Close (30-Jun) $11.22 -0.22 (-1.92%)	Volume (30-Jun) 664,557	Shortsold (19-Oct) 36,725,267 (10.79%) (11th)
52w High $18.22	52w Low $8.26	P/E 250.00	EPS 0.15

[ARTICLE] Fund managers back market darling Telix Pharmaceuticals

MediaBot

August 4, 2022 15:38

A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around August 4, 2022 15:38, on 4 August 2022 at 3:38pm.

A bevvy of healthcare analysts and Australian equities managers have profited from buying fast-rising oncology business Telix, after it unveiled strong sales.

Read Article

TLX was $7.42 at the close of trade on 03 August 2022

Recent Articles about ASX:TLX
14-Sep	FDA Approves Telix's Brain Cancer Imaging Drug Pixclara - AFR company-announcements.afr.com
13-Sep	Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with ... company-announcements.afr.com
13-Sep	Telix Appoints David Gill as Chair - ASX Announcement - Market Index company-announcements.afr.com
21-Jul	Notice of change of interests of substantial holder - AFR company-announcements.afr.com
21-Jul	Q2 Business Update - Telix Pharmaceuticals Limited company-announcements.afr.com
19-Jul	Appendix 3H - Notification of cessation of securities - AFR company-announcements.afr.com
17-Jul	Appendix 3G - Notification of issue, conversion or payment up ... - AFR company-announcements.afr.com
4-Jul	Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement company-announcements.afr.com
3-Jul	604 Page 1 of 6 - Market Index company-announcements.afr.com
3-Jul	Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain ... company-announcements.afr.com
Tracked

Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

End of Day Prices

Date	Close	Volume	Change
23-Oct	$13.19	3,151,131	-0.47 (3.44%)
22-Oct	$13.66	4,272,393	-0.86 (5.92%)
21-Oct	$14.52	4,382,368	-1.24 (7.87%)
20-Oct	$15.76	1,197,406	+0.36 (2.34%)
19-Oct	$15.40	1,107,461	-0.33 (2.10%)
16-Oct	$15.73	1,326,481	+0.65 (4.31%)
15-Oct	$15.08	1,815,274	-0.26 (1.69%)
14-Oct	$15.34	1,104,996	-0.44 (2.79%)
13-Oct	$15.78	1,317,037	-0.52 (3.19%)
12-Oct	$16.30	1,208,628	+0.45 (2.84%)
09-Oct	$15.85	1,026,543	0.00 (0.00%)
08-Oct	$15.85	1,297,945	-0.02 (0.13%)
07-Oct	$15.87	2,364,422	+0.46 (2.99%)
06-Oct	$15.41	1,114,504	-0.14 (0.90%)
05-Oct	$15.55	1,268,082	+0.39 (2.57%)
5 up, 9 down, and 1 flat days

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

[ARTICLE] Fund managers back market darling Telix Pharmaceuticals

MediaBot

Followers

Prices

Announcements

End of Day Prices

Telix Pharmaceuticals Health Care Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

[ARTICLE] Fund managers back market darling Telix Pharmaceuticals

MediaBot

Followers

Prices

Announcements

End of Day Prices

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom